Active Ingredient History

  • Now
Retapamulin is a topical antibiotic which was approved by FDA (Altabax brand name) for the treatment of impetigo due to Staphylococcus aureus (methicillin-susceptible isolates only) or Streptococcus pyogenes. Retapamulin exerts its antibacterial action by binding to 50S subunit of the bacterial ribosome.   NCATS

  • SMILES: C[C@@H]1CC[C@@]23CCC(=O)[C@H]2[C@]1(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]3C)OC(=O)CS[C@@H]4C[C@H]5CC[C@@H](C4)N5C
  • Mol. Mass: 517.78
  • ALogP: 5.25
  • ChEMBL Molecules:
More Chemistry

Drug Pricing (per unit)

United States

$14.1580 - $18.4820
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

aitabax | altabax | altargo | mutilin | retapamulin | retpamulin | sb275833 | sb 275833 | sb-275833


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue